These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10536179)

  • 1. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
    Ulsperger E; Hamilton G; Raderer M; Baumgartner G; Hejna M; Hoffmann O; Mallinger R
    Int J Oncol; 1999 Nov; 15(5):955-9. PubMed ID: 10536179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factors.
    Ulsperger E; Hamilton G; Olszewski U; Baumgartner G; Engel A; Mallinger R
    Oncol Rep; 2003; 10(5):1529-34. PubMed ID: 12883736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CD99/MIC2 expression of human AHTO-7 osteoblasts by carcinoma cell line-conditioned media.
    Hamilton D; Mallinger R; Millesi H; Engel A; Baumgartner G; Raderer M
    Anticancer Res; 2001; 21(6A):3909-13. PubMed ID: 11911268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells.
    Mizutani K; Ikeda K; Kawai Y; Yamori Y
    Biochem Biophys Res Commun; 1998 Dec; 253(3):859-63. PubMed ID: 9918820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells.
    Kanno S; Hirano S; Kayama F
    Toxicology; 2004 Mar; 196(1-2):137-45. PubMed ID: 15036763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
    Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol Attenuates Lipopolysaccharides (LPS)-Induced Inhibition of Osteoblast Differentiation in MC3T3-E1 Cells.
    Ma J; Wang Z; Zhao J; Miao W; Ye T; Chen A
    Med Sci Monit; 2018 Apr; 24():2045-2052. PubMed ID: 29624568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP.
    Mitchell JH; Duthie SJ; Collins AR
    Nutr Cancer; 2000; 38(2):223-8. PubMed ID: 11525601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells.
    Bhattacharyya RS; Stern PH
    J Cell Biochem; 2003 Dec; 90(5):925-37. PubMed ID: 14624452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
    Gehm BD; McAndrews JM; Chien PY; Jameson JL
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14138-43. PubMed ID: 9391166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
    Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
    J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts.
    Pinski J; Parikh A; Bova GS; Isaacs JT
    Cancer Res; 2001 Sep; 61(17):6372-6. PubMed ID: 11522628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic insertion of the SV-40 large T oncogene in normal adult human trabecular osteoblastic cells induces cell growth without loss of the differentiated phenotype.
    Lomri A; Fromigué O; Hott M; Marie PJ
    Calcif Tissue Int; 1999 May; 64(5):394-401. PubMed ID: 10203416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts.
    Yohay DA; Zhang J; Thrailkill KM; Arthur JM; Quarles LD
    J Cell Physiol; 1994 Mar; 158(3):467-75. PubMed ID: 8126070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow.
    Lang SH; Miller WR; Habib FK
    Prostate; 1995 Nov; 27(5):287-93. PubMed ID: 7479396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro.
    Kido J; Yamauchi N; Ohishi K; Kataoka M; Nishikawa S; Nakamura T; Kadono H; Ikedo D; Ueno A; Nonomura N; Okuyama A; Nagata T
    J Cell Biochem; 1997 Nov; 67(2):248-56. PubMed ID: 9328830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
    Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
    Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.